Zemplar Related Clinical Trials
Paricalcitol Injection Phase II Trial [Completed]
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection [Completed]
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate [Recruiting]
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice [Recruiting]
Oral Paricalcitol in Kidney Transplant Recipients [Recruiting]
Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D [Recruiting]
A Study of Paricalcitol Synergism in Conjunction With Standard-of-Care Chemo-Radiation for Resectable Rectal Cancers [Recruiting]
Vitamin D and Coronary Calcification Study [Recruiting]
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children 10-16 With Chronic Kidney Disease (CKD) [Recruiting]
A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis [Completed]
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism [Recruiting]
Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism [Recruiting]
Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients [Recruiting]
Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery [Recruiting]
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol [Recruiting]
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis [Recruiting]
Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes [Recruiting]
Metabolic Effects of Paricalcitol [Recruiting]
Study to Evaluate the Effect of Zemplar on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years [Recruiting]
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer [Recruiting]
Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria [Not yet recruiting]
A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors [Recruiting]
Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease [Recruiting]
Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous [Recruiting]
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) [Recruiting]
Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT) [Recruiting]
Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer [Recruiting]
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis [Recruiting]
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects [Completed]
Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis [Terminated]
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation [Recruiting]
Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo [Recruiting]
The PRIMO Study-Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Chronic Kidney Disease Stage 3B/4 [Recruiting]
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With CKD Stage 5 [Recruiting]
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-Linked Hypophosphatemic Rickets [Recruiting]
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases [Recruiting]
Long-Term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With HD [Not yet recruiting]
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients [Completed]
A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis [Completed]
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium [Completed]
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects [Recruiting]
Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease [Recruiting]
Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients [Not yet recruiting]
The Effects of Active VItamin D on Left Atrial Volume Index [Not yet recruiting]
Dose-Response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis (HD) [Recruiting]
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism [Not yet recruiting]
Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis [Completed]
Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose [Recruiting]
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Recruiting]
Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis [Completed]
Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation [Recruiting]
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [Completed]
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [Completed]
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy [Not yet recruiting]
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) [Completed]
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease [Recruiting]
Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis [Completed]
Paricalcitol in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]
Treatment of Secondary Hyperparathyroidism in the Uremic Patient [Recruiting]
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism [Completed]
Therapy With Oral Paricalcitol Tabs in Non Hemodialysis Chronic Kidney Disease Patients [Recruiting]
Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D [Recruiting]
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease [Recruiting]
A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease [Recruiting]
Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients [Not yet recruiting]
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients [Recruiting]
Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease [Recruiting]
Vitamin D, Insulin Resistance and Inflammation in ESRD [Recruiting]
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy [Not yet recruiting]
Immune Effects of Vitamin D in Hemodialysis Patients [Completed]
A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism [Recruiting]
Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients [Recruiting]
Comparison of Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Stage Three and Four [Recruiting]
|
